Loading data
XNCRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 125.58 m USD | 110.49 m USD | 174.62 m USD | 164.58 m USD | 275.11 m USD |
| Research and development expense | 239.43 m USD | 227.69 m USD | 253.6 m USD | 199.56 m USD | 192.51 m USD |
| Operating profit | -177.5 m USD | -178.41 m USD | -132.36 m USD | -82.47 m USD | 43.77 m USD |
| Interest expense | — | — | 6.18 m USD | 13 k USD | 13 k USD |
| Profit before tax | -89.63 m USD | -234.92 m USD | -119.63 m USD | -54.51 m USD | 82.63 m USD |
| Income tax expense | 2.5 m USD | 1.62 m USD | 13.66 m USD | 673 k USD | 0 USD |
| Net income (reported basis) | -91.92 m USD | -232.62 m USD | -133.13 m USD | -55.18 m USD | 82.63 m USD |
| Net income attributable to common shareholders | -91.92 m USD | -232.62 m USD | -133.13 m USD | -55.18 m USD | 82.63 m USD |
| Basic earnings per share | -1.24 USD/share | -3.58 USD/share | -2.2 USD/share | -0.93 USD/share | 1.42 USD/share |
| Diluted earnings per share | -1.24 USD/share | -3.58 USD/share | -2.2 USD/share | -0.93 USD/share | 1.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.